Agilent Technologies, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Padraig McDonnell
- Full Time Employees
- 18,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 5301 Stevens Creek Boulevard Santa Clara CA United States of America 95051
- IPO Date
- Nov 18, 1999
- CIK
- 0001090872
- Website
- agilent.com
- Similar Companies
- Business
- Agilent Technologies, Inc. (NYSE: A) provides instruments, software, services, and consumables for the life sciences, diagnostics, chemical analysis, and applied markets. The company offers a broad portfolio of products and services including gas chromatography and liquid chromatography systems; mass spectrometry and molecular spectroscopy instruments; microarrays, automation, and informatics solutions; bioreagents, FISH probes, target enrichment, and next-generation sequencing tools; immunohistochemistry and pathology solutions; genomics, proteomics, and cell analysis platforms; sample preparation, GC and HPLC columns, spectrometry supplies, and consumables; as well as laboratory management services encompassing enterprise asset management, compliance support, training, and CrossLab virtual assist for remote technical support. Headquartered in Santa Clara, California, Agilent operates globally in more than 100 countries, serving analytical laboratories, pharmaceutical, biopharma, clinical diagnostics, environmental, forensics, food, energy, academia, and government sectors; it was spun off from Hewlett-Packard in 1999. Recent developments include the completion of its $925 million acquisition of BIOVECTRA, Inc., a Canada-based contract development and manufacturing organization specializing in biologics, active pharmaceutical ingredients, sterile fill-finish, plasmid DNA, mRNA, lipid nanoparticles, antibody-drug conjugates, and high-potency APIs, enhancing Agilent's CDMO capabilities for gene editing and therapeutics; a $7 million investment to modernize R&D and applications labs in Delaware; the launch of the Agilent Innovation Hub in partnership with the University of Melbourne; a strategic collaboration with SeqOne for liquid biopsy data analysis in oncology; and expansions such as a $725 million nucleic acid therapeutics facility in Frederick, Colorado, alongside new product launches driving growth in specialty CDMO services for siRNA and GLP-1 modalities.
MDT vs. A: Which Stock Should Value Investors Buy Now?
BIP Wealth LLC Makes New $834,000 Investment in Agilent Technologies, Inc. $A
Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.
Comparing Agilent Technologies (NYSE:A) & Many Bright Ideas Technologies (OTCMKTS:MBGNF)
Ashton Thomas Securities LLC Buys 6,387 Shares of Agilent Technologies, Inc. $A
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Agilent Increases Its Investment in HALO X-ray Technologies
Dividend Champion, Contender, And Challenger Highlights: Week Of July 19
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Alpha and Omega Semiconductor Unveils AmpStack™ Packaging: A Leap Forward in MOSFET Power Density
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Agilent Completes Acquisition of Biocare Medical
Canadian Apartment REIT: A 4.5% Dividend Yield With Ample Coverage
Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky